当前位置: X-MOL 学术Obesity › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impact of Acipimox Therapy on Free Fatty Acid Efflux and Endothelial Function in the Metabolic Syndrome: A Randomized Trial.
Obesity ( IF 4.2 ) Pub Date : 2019-10-01 , DOI: 10.1002/oby.22602
Aaron W Aday 1 , Allison B Goldfine 2, 3 , Justin M Gregory 4 , Joshua A Beckman 1
Affiliation  

Insulin resistance is associated with increased lipolysis and elevated concentrations of free fatty acids (FFA), which in turn contribute to impaired vascular function. It was hypothesized that lowering FFA with acipimox, a nicotinic acid derivative that impairs FFA efflux, would improve endothelial function, measured by flow‐mediated dilation (FMD), in individuals with metabolic syndrome.

中文翻译:

Acipimox治疗对代谢综合征中游离脂肪酸流出和内皮功能的影响:一项随机试验。

胰岛素抵抗与脂肪分解增加和游离脂肪酸(FFA)浓度升高有关,这反过来又导致血管功能受损。据推测,用阿西莫克斯(一种降低了FFA外排的烟酸衍生物)降低FFA,可以改善代谢综合征患者的血管内皮功能(通过流介导的扩张(FMD)来衡量)。
更新日期:2019-10-01
down
wechat
bug